A research team at Osaka University developed the Japanese version of the Rare and Undiagnosed Diseases Study (RUDY), RUDY JAPAN. Through collaboratio...
The use of the antibiotic colistin, a last-resort treatment option in the infection by multidrug-resistant bacteria, is increasingly impeded by colist...
